Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M E Davis

Showing results (321-330 of 326) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 326 results.
Scientific Reports|October 12, 2021
A comparison of the clinical, laboratory and epidemiological features of two divergent subpopulations of Plasmodium knowlesiTing Huey Hu, Nawal Rosli, Dayang S A Mohamad, et al.
Plos Medicine|June 13, 2018
Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysisFrank Kloprogge, Lesley Workman, Steffen Borrmann, et al.
Plos Medicine|October 5, 2019
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Nature Genetics|November 13, 2012
Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargementYu Sun, Beata Bak, Nadia Schoenmakers, et al.
Plos Medicine|November 19, 2020
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance NetworkMohammad S Hossain, Robert J Commons, Nicholas M Douglas, et al.
The American Journal of Tropical Medicine and Hygiene|July 23, 2014
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquineMeera Venkatesan, Nahla B Gadalla, Kasia Stepniewska, et al.
Pageof 33

Showing results (321-330 of 326) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 326 results.
Scientific Reports|October 12, 2021
A comparison of the clinical, laboratory and epidemiological features of two divergent subpopulations of Plasmodium knowlesiTing Huey Hu, Nawal Rosli, Dayang S A Mohamad, et al.
Plos Medicine|June 13, 2018
Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysisFrank Kloprogge, Lesley Workman, Steffen Borrmann, et al.
Plos Medicine|October 5, 2019
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Nature Genetics|November 13, 2012
Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargementYu Sun, Beata Bak, Nadia Schoenmakers, et al.
Plos Medicine|November 19, 2020
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance NetworkMohammad S Hossain, Robert J Commons, Nicholas M Douglas, et al.
The American Journal of Tropical Medicine and Hygiene|July 23, 2014
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquineMeera Venkatesan, Nahla B Gadalla, Kasia Stepniewska, et al.
Pageof 33